We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Controlling Bleeding When Tourniquets Won’t Suffice

By HospiMedica International staff writers
Posted on 06 Feb 2013
An innovative belt-like device helps control acute bleeding in the groin and inguinal region during emergency and battlefield situations. More...


The Junctional Emergency Treatment Tool (JETT) provides two pressure pads in a single device with the ability to treat both unilateral and bilateral injuries, thereby stopping blood flow to the lower extremities without impeding respiration. It is configured for easy, rapid, deployment and it comes preassembled and ready for use in a compact, vacuum-sealed pouch. The JETT is rugged enough to withstand the rigors of austere environments, and is also designed to allow for patient movement without dislodging or reducing pressure, enabling it to be effectively utilized in triage during the prehospital environment.

The JETT offers a treatment solution for what has become the new leading cause of preventable combat death—junctional hemorrhage, injuries due to explosive blasts and penetrating trauma located too high in the groin or inguinal space to be treated by standard tourniquet devices. An important advantage is that the JETT is a mechanical device (rather than a pneumatic or air inflated device), thus maintaining steady pressure on the injury regardless of atmospheric pressure changes, and without fear of puncture or damage to an air bladder. The JETT device is a product of North American Rescue (NAR; Greer, SC, USA), and has been approved by the US Food and Drug Administration (FDA).

“Having recognized the gap in first line tactical casualty care, we designed the JETT to be applied quickly, easily and accurately in difficult conditions,” said Joanne Walter, senior vice president of product management at NAR. “Development of the JETT has been an excellent opportunity to work closely with key prehospital medical practitioners in order to understand the specific needs that they have and provide a solution that clearly exceeds anything currently available.”

“Today, high extremity wounds in the thigh/groin account for up to 20% of preventable deaths on the modern battlefield,” said Major General (retired) Lester Martinez-Lopez, MD, MPH, US Army. “Previously, the majority of preventable deaths were attributed to extremity hemorrhage from gunshot or blast injuries, but recent data from the battlefield and the widespread success of the windlass tourniquet in use by military forces has warranted a new focus in tactical casualty care.”

Related Links:
North American Rescue


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.